(Q37380424)
Statements
1 reference
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer (English)
1 reference
Nikolaus Schultz
1 reference
Lorenza Mittempergher
1 reference
Astrid J Bosma
1 reference
Eileen Holmes
1 reference
Christos Sotiriou
1 reference
Debora Fumagalli
1 reference
Jose Jimenez
1 reference
Claudia Aura
1 reference
Ludmila Prudkin
1 reference
Maria Carmen Díaz-Delgado
1 reference
Lorena de la Peña
1 reference
Catherine Ellis
1 reference
José Baselga
1 reference
5 January 2015
1 reference
1 reference
1334-1339
1 reference
Identifiers
1 reference
1 reference
1 reference